Memorial Sloan Kettering Cancer Center

Patients with both multiple myeloma and diabetes experienced reduced OS compared with those without diabetes, according to study results published in Blood Advances.

Patients with metastatic breast cancer treated with alpelisib as standard care had elevated blood glucose levels compared with those who received the drug as part of a clinical trial, according to data published in Cancer.

Researchers developed and evaluated streamlined models for predicting and preventing breast cancer-related lymphedema.

Now that chimeric antigen receptor T-cell therapy has become part of the treatment landscape in hematologic malignancies, researchers are focused on developing more potent, less toxic agents that can be used in earlier treatment settings.

Damon Reed, MD, has been appointed inaugural head of the division of pediatric solid tumors at Memorial Sloan Kettering Cancer Center.

SANTA FE, N.M. — In this video exclusive, Azeez Farooki, MD, discusses considerations when dealing with bone loss and elevated fracture risk resulting from treatments for breast and prostate cancer.

Multifocal disease is not linked to a greater risk of recurrence or mortality for children and adolescents with papillary thyroid carcinoma, according to a study published in The Journal of Clinical Endocrinology & Metabolism.

The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country.

Liver transplant conferred a 10-year OS rate of more than 80% in selected patients with colorectal cancer and nonresectable liver metastases, study results showed.

Pirtobrutinib appeared effective among a cohort of heavily pretreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma, according to study results published in The New England Journal of Medicine.